Paris, France

Helmut Ankel

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1977.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Helmut Ankel. Retrieved from https://idiyas.com/inventor/helmut-ankel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Helmut Ankel: Innovator in Pharmaceutical Formulations

Introduction

Helmut Ankel is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of interferon. His innovative approach has led to advancements that could impact various medical treatments.

Latest Patents

Helmut Ankel holds a patent for a pharmaceutical formulation of interferon that has been rendered insoluble by being coupled to a support, such as sepharose. This formulation represents a breakthrough in the delivery and efficacy of interferon as a therapeutic agent. He has 1 patent to his name, showcasing his expertise in this specialized area.

Career Highlights

Throughout his career, Helmut has focused on developing pharmaceutical products that enhance the stability and effectiveness of active ingredients. His work has been instrumental in advancing the understanding of interferon applications in medicine.

Collaborations

Helmut Ankel has collaborated with esteemed colleagues, including Charles Chany and Brigitte Galliot. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Helmut Ankel's contributions to pharmaceutical formulations highlight his role as a key innovator in the field. His work continues to influence the development of effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…